Adamis Pharma News

ADMPDelisted Stock  USD 0.56  0.02  3.45%   
Slightly above 62% of Adamis Pharma's investor base is looking to short. The analysis of current outlook of investing in Adamis Pharma suggests that many traders are alarmed regarding Adamis Pharma's prospects. Adamis Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in Adamis Pharma. The current market sentiment, together with Adamis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Adamis Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adamis Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Adamis daily returns and investor perception about the current price of Adamis Pharma as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Allergic Rhinitis Drugs Market 2023-2031 Market Insight by Recent Developments and Gross Margin with...
Google News at Macroaxis
over six months ago at news.google.com         
Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight...
Google News at Macroaxis
over six months ago at news.google.com         
Allergic Rhinitis Drugs Market Size and Regional Outlook Analysis 2023-2030 - Benzinga
Google News at Macroaxis
over six months ago at seekingalpha.com         
Adamis Pharmaceuticals GAAP EPS of -3.40
seekingalpha News
over six months ago at finance.yahoo.com         
Adamis Q2 Earnings Snapshot
Yahoo News
over six months ago at globenewswire.com         
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Macroaxis News: globenewswire.com
over six months ago at thelincolnianonline.com         
Adamis Pharmaceuticals Research Coverage Started at StockNews.com
news
over six months ago at finance.yahoo.com         
Adamis Pharmaceuticals Announces Closing of 8.0 Million Public Offering
Yahoo News
over six months ago at benzinga.com         
Adamis Pharmaceuticals Announces Closing of 8.0 Million Public Offering
benzinga news
over six months ago at globenewswire.com         
Adamis Pharmaceuticals Announces Closing of 8.0 Million Public Offering
Macroaxis News: globenewswire.com
over six months ago at seekingalpha.com         
FVRR, CHRS and NVBSE are among pre market gainers
seekingalpha News
over six months ago at Macroaxis         
Will Adamis Pharma (USA Stocks:ADMP) turn things around in September?
Macroaxis News
over six months ago at marketwatch.com         
Adamis Pharmaceuticals Units Drop 66 percent After 8M Offering Prices
marketwatch News
over six months ago at seekingalpha.com         
Adamis Pharmaceuticals down after announcing pricing of 8M public offering
seekingalpha News
over six months ago at benzinga.com         
Adamis Pharmaceuticals Announces Pricing of 8.0 Million Public Offering
benzinga news
Far too much social signal, news, headlines, and media speculation about Adamis Pharma that are available to investors today. That information is available publicly through Adamis media outlets and privately through word of mouth or via Adamis internal channels. However, regardless of the origin, that massive amount of Adamis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Adamis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adamis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adamis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adamis Pharma alpha.

Adamis Pharma Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Tasso, United BioSource partner to improve sample collection - FierceBiotech
07/05/2023
2
Adamis Pharmaceuticals to Fund ZIMHI Clinical Study with University of Leiden Opioid Expert - Marketscreener.com
07/31/2023
3
Will Adamis Pharma turn things around in September
08/02/2023
4
Adamis Pharmaceuticals Announces Closing of 8.0 Million Public Offering
08/04/2023
5
Adamis Q2 Earnings Snapshot
08/21/2023
6
Adamis Pharmaceuticals GAAP EPS of -3.40
08/22/2023
7
Allergic Rhinitis Drugs Market 2023-2031 Market Insight by Recent Developments and Gross Margin with 1 - Benzinga
09/20/2023
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Adamis Stock

If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing